132 related articles for article (PubMed ID: 8391870)
21. Effects of plasmin on rabbit platelets.
Guccione MA; Kinlough-Rathbone RL; Packham MA; Harfenist EJ; Rand ML; Greenberg JP; Perry DW; Mustard JF
Thromb Haemost; 1985 Feb; 53(1):8-14. PubMed ID: 3158094
[TBL] [Abstract][Full Text] [Related]
22. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
23. Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation.
Molino M; Bainton DF; Hoxie JA; Coughlin SR; Brass LF
J Biol Chem; 1997 Feb; 272(9):6011-7. PubMed ID: 9038223
[TBL] [Abstract][Full Text] [Related]
24. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
25. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF
Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764
[TBL] [Abstract][Full Text] [Related]
26. Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin and thrombin receptor agonist peptide in human platelets. Evidence for activation of cPLA2 independent of the mitogen-activated protein kinases ERK1/2.
Kramer RM; Roberts EF; Hyslop PA; Utterback BG; Hui KY; Jakubowski JA
J Biol Chem; 1995 Jun; 270(24):14816-23. PubMed ID: 7782348
[TBL] [Abstract][Full Text] [Related]
27. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
28. Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction.
Lasne D; Donato J; Falet H; Rendu F
Thromb Haemost; 1995 Nov; 74(5):1323-8. PubMed ID: 8607117
[TBL] [Abstract][Full Text] [Related]
29. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
[TBL] [Abstract][Full Text] [Related]
30. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
Tymkewycz PM; Jones RL; Wilson NH; Marr CG
Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of species differences in the platelet ADP and thrombin response.
Nylander S; Mattsson C; Lindahl TL
Thromb Res; 2006; 117(5):543-9. PubMed ID: 15921723
[TBL] [Abstract][Full Text] [Related]
33. Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation.
Coller BS; Springer KT; Scudder LE; Kutok JL; Ceruso M; Prestwich GD
J Biol Chem; 1993 Oct; 268(28):20741-3. PubMed ID: 8104935
[TBL] [Abstract][Full Text] [Related]
34. Platelet release reaction and aggregation induced by canatoxin, a convulsant protein: evidence for the involvement of the platelet lipoxygenase pathway.
Carlini CR; Guimarães JA; Ribeiro JM
Br J Pharmacol; 1985 Feb; 84(2):551-60. PubMed ID: 3919794
[TBL] [Abstract][Full Text] [Related]
35. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
Huzoor-Akbar ; Anwer K
Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
[TBL] [Abstract][Full Text] [Related]
36. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
[TBL] [Abstract][Full Text] [Related]
37. Thrombin-induced inositol trisphosphate production by rabbit platelets is inhibited by ethanol.
Rand ML; Vickers JD; Kinlough-Rathbone RL; Packham MA; Mustard JF
Biochem J; 1988 Apr; 251(1):279-84. PubMed ID: 3260489
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
39. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.
Chao BH; Kalkunte S; Maraganore JM; Stone SR
Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929
[TBL] [Abstract][Full Text] [Related]
40. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
Gross PL; Rand ML; Barrow DV; Packham MA
Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
